Chronic Renal Insufficiency Cohort Study III (CRIC-3)

$925,000U01FY2015DKNIH

Kaiser Foundation Research Institute, Oakland CA

Investigators

Linked publications & trials

Paper 39198916 Paper 39131916 Paper 39115956 Paper 39115897 Paper 39087321 Paper 39032679 Paper 38935492 Paper 38583756 Paper 38435069 Paper 38266973 Paper 38212425 Paper 38103719 Paper 37889527 Paper 37816758 Paper 37741609 Paper 37717847 Paper 37717845 Paper 37616058 Paper 37609990 Paper 37450064 Paper 37441488 Paper 37429030 Paper 37421259 Paper 37273234 Paper 37258540 Paper 37245689 Paper 37205602 Paper 37178093 Paper 37100172 Paper 37014015 Paper 36935072 Paper 36814088 Paper 36738890 Paper 36502797 Paper 36403887 Paper 36288905 Paper 36102277 Paper 36100915 Paper 36093899 Paper 35817274 Paper 35810825 Paper 35777833 Paper 35746879 Paper 35405207 Paper 35372819 Paper 35343329 Paper 35278374 Paper 35226897 Paper 35072049 Paper 35061809 Paper 35007146 Paper 34763078 Paper 34697628 Paper 34656710 Paper 34597264 Paper 34554660 Paper 34554658 Paper 34465608 Paper 34339746 Paper 34293394 Paper 34195833 Paper 34175376 Paper 34169199 Paper 34052355 Paper 34029681 Paper 33857532 Paper 33851116 Paper 33735863 Paper 33732981 Paper 33661286 Paper 33479519 Paper 33462081 Paper 33421453 Paper 33367652 Paper 33326030 Paper 33309860 Paper 33306688 Paper 33301877 Paper 33177074 Paper 33163721 Paper 33161774 Paper 33144501 Paper 33122288 Paper 33117990 Paper 33089138 Paper 33023926 Paper 32973085 Paper 32873054 Paper 32866540 Paper 32798563 Paper 32768632 Paper 32707221 Paper 32664108 Paper 32578483 Paper 32576601 Paper 32503932 Paper 32387023 Paper 32317121 Paper 32282046 Paper 32217634

Abstract

DESCRIPTION (provided by applicant): Between 2002-2012, the NIDDK sponsored Phases 1 and 2 of the prospective Chronic Renal Insufficiency Cohort (CRIC) Study, which enrolled >3,900 adults with chronic kidney disease at seven Clinical Centers to address the overarching goals of identifying risk factors for kidney disease progression and clarifying the relationship between renal dysfunction and the risks of subclinical and clinical cardiovascular events, death, and resource utilization. The initial five-year follow-up of Phase 1 was extended by an additional five years in Phase 2, which ends April 2013. The proposed CRIC-Phase 3 offers a unique opportunity to leverage the existing effort and success of CRIC by extending the follow-up for the existing cohort to June 2018; by recruiting and following a new cohort of 1,500 individuals with less severe CKD; and by evaluating a more comprehensive set of exposures and outcomes. CRIC-Phase 3 will become an unparalleled resource that will expand the science related to chronic kidney disease natural history as well as the impact of kidney dysfunction on the development and progression of cardiovascular disease and other adverse events. Specific Aims to be addressed by the Kaiser Permanente Northern California/University of California, San Francisco Clinical Center are: 1. To re-enroll a high percentage of CRIC-Phase 1 participants into CRIC-Phase 3. 2. To recruit and enroll an additional cohort of 215 participants with less severe CKD into CRIC-Phase 3. 3. To collect exposure and outcome data per the CRIC-Phase 3 protocol.4.To maintain high levels of retention in the study. 5. To investigate clinical events and obtain supporting medical records and documentation. 6. To enter data and process/ship biological specimens. 7. To implement local quality assurance and quality control procedures as a means to obtain standardized, high quality measurements. 8. To monitor data collection, data entry, and follow-up rates. 9. To participate in governance and oversight of CRIC through study-wide subcommittees and activities. 10. To publish and present findings from the CRIC Study. 11. To promote and support the conduct of ancillary studies in CRIC, including collaboration with the broader nephrology research community.

View original record on NIH RePORTER →